LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3 - Amendment to Purchases & Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. | |
Company dealt in | WILLIS TOWERS WATSON PLC | |
Class of relevant security to which the | ORD | |
dealings being disclosed relate (Note 2) | ||
Date of dealing | 16 July 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: | ORD | ||||
Long | Short | ||||
Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
1,892,713 |
1.47% |
240,773 |
0.19% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
1,359 |
0.00% |
158,150 |
0.12% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
purchase/sell: | 6,100 |
0.00% |
6,100 |
0.00% |
|
|
|
|
|
||
TOTAL: |
|
|
|
|
|
1,900,172 |
1.47% |
405,023 |
0.31% |
||
|
|
|
|
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
13 |
222.1492 USD |
Purchase |
20 |
221.4400 USD |
Purchase |
45 |
221.8700 USD |
Purchase |
76 |
222.2400 USD |
Purchase |
92 |
222.1300 USD |
Purchase |
99 |
221.8900 USD |
Purchase |
100 |
223.1383 USD |
Purchase |
100 |
222.0500 USD |
Purchase |
230 |
221.7332 USD |
Purchase |
264 |
222.1637 USD |
Purchase |
272 |
221.5638 USD |
Purchase |
280 |
222.2900 USD |
Purchase |
349 |
221.8907 USD |
Purchase |
762 |
222.3245 USD |
Purchase |
953 |
222.3394 USD |
Purchase |
960 |
221.6355 USD |
Purchase |
1,245 |
221.9662 USD |
Purchase |
1,333 |
222.4935 USD |
Purchase |
1,680 |
221.8260 USD |
Purchase |
1,766 |
222.8248 USD |
Purchase |
1,857 |
221.8395 USD |
Purchase |
2,206 |
222.3018 USD |
Purchase |
2,751 |
222.6754 USD |
Purchase |
2,972 |
222.3600 USD |
Purchase |
3,208 |
221.9241 USD |
Purchase |
3,208 |
222.6663 USD |
Purchase |
3,851 |
222.4435 USD |
Purchase |
5,283 |
222.4936 USD |
Purchase |
6,000 |
220.0000 USD |
Sale |
5 |
222.2800 USD |
Sale |
6 |
221.9700 USD |
Sale |
22 |
223.3100 USD |
Sale |
22 |
221.8272 USD |
Sale |
100 |
222.0200 USD |
Sale |
100 |
221.7800 USD |
Sale |
100 |
222.9200 USD |
Sale |
120 |
221.7840 USD |
Sale |
186 |
222.7713 USD |
Sale |
320 |
222.0962 USD |
Sale |
380 |
222.2900 USD |
Sale |
618 |
222.3664 USD |
Sale |
953 |
222.3394 USD |
Sale |
961 |
222.3600 USD |
Sale |
1,026 |
222.2831 USD |
Sale |
1,796 |
222.4245 USD |
Sale |
1,915 |
222.3497 USD |
Sale |
2,200 |
222.4789 USD |
Sale |
2,206 |
222.3018 USD |
Sale |
2,451 |
222.7410 USD |
Sale |
4,609 |
222.6126 USD |
Sale |
5,881 |
222.6165 USD |
Sale |
10,000 |
221.8551 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD |
Nature of transaction (Note 6) |
Number of relevant securities (Note 7) |
Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? | YES |
Date of disclosure: | 20 Jul 2021 |
Contact name: | Large Holdings Regulatory Operations |
Telephone number: | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected | |
If a connected EFM, state nature of connection |
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name | Written or | Number of | Exercise | Type | Expiry |
purchased | relevant securities | price | date | ||
to which the option | |||||
or derivative | |||||
relates | |||||
Put Options |
Purchased |
-100 |
220.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
100 |
240.0000 |
American |
Jul 16, 2021 |
Call Options |
Purchased |
6,000 |
220.0000 |
American |
Jul 16, 2021 |
Put Options |
Purchased |
-6,000 |
200.0000 |
American |
Jul 16, 2021 |
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.